fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
fincash number+91-22-62820123
All Best Performing Equity Mutual Funds 2020 | Fincash.com

Fincash » Mutual Funds » Best Equity Funds

Best Equity Mutual Funds To Invest In 2020

Updated on November 26, 2020 , 20670 views

An equity fund is a mutual fund that invests principally in stocks. It can be actively or passively (index fund) managed. Equity Funds are also known as stock funds.

Best Equity Funds

Equity funds should be the vehicle of choice when Investing for long-term goals. Equity funds have created huge profits for investors in the past few years. But as there is a wide choice before investors, choosing the right equity fund becomes critical. But with right qualitative and quantitative measures (discussed below), one can ideally choose the best equity Mutual Funds.

Why to Invest in Equity Funds?

1. Liquidity

Since stocks are actively traded across all major exchanges, every day, this makes equity funds a highly liquid investment. It provides investors, the convenience of buying and selling their stocks depending on the market situation. By investing in equity mutual funds, the money is usually credited to your bank account in 3 days.

2. Dividend Income

Investing into blue-chip companies may help investors earn a steady income in the form of dividends. A majority of such companies usually pay out regular dividends even in volatile market conditions, typically paid quarterly. Having a diversified portfolio can provide investors with a steady dividend income in the year.

3. Portfolio Diversification

With best equity mutual funds investors can diversify their portfolio through regularly investing. It means that they can invest in stocks of different economic sectors. So, even if a particular stock drops in value, the others may help investors make up for that loss depending on the market situation.

4. Ideal Investment Vehicle

In many ways, equity funds are ideal investment vehicles for investors that are not as well-versed in financial investing or do not possess a large amount of capital with which to invest. Equity funds are practical investments for most people.

The attributes that make equity funds most suitable for small individual investors are the reduction of risk resulting from a fund's portfolio diversification and the relatively small amount of capital required to acquire shares of an equity fund. A large amount of investment capital would be required for an individual investor to achieve a similar degree of risk reduction through diversification of a portfolio of direct stock holdings. Pooling small investors capital allows an equity fund to diversify effectively without burdening each investor with large capital requirements.

The price of the equity fund is based on the fund's net asset value (NAV) less its liabilities. A more diversified fund means that there is less negative effect of an individual stock's adverse price movement on the overall portfolio and on the share price of the equity fund.

Equity funds are managed by experienced professional portfolio managers, and their past performance is a matter of public record. Transparency and reporting requirements for equity funds are heavily regulated by the Security Exchange Board of India (SEBI)

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Top Equity Mutual Funds 2020

Best equity mutual funds are categorised according to its types- ELSS, Large cap funds, mid cap funds, Small cap funds, Diversified Funds, sector funds and Balanced Fund.

5 Best Large Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
Axis Bluechip Fund Growth ₹35.43
₹18,28312.933.211.712.813.318.6
Kotak Bluechip Fund Growth ₹274.28
↑ 0.73
₹1,74011.738.69.77.59.914.2
SBI Bluechip Fund Growth ₹45.082
↑ 0.13
₹22,42112.840.38.65.89.811.6
ICICI Prudential Bluechip Fund Growth ₹46.65
↓ -0.10
₹23,4869.833.85.95.110.29.8
DSP BlackRock TOP 100 Equity Growth ₹226.102
↓ -0.61
₹2,36911.835.20.64.48.114.8
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Mid Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
Axis Mid Cap Fund Growth ₹47.67
↑ 0.88
₹6,94912.637.121.21313.711.3
DSP BlackRock Midcap Fund Growth ₹69.031
↑ 1.45
₹8,40711.54122.57.313.29.2
Invesco India Mid Cap Fund Growth ₹59.3
↑ 0.96
₹1,00910.739.620.86.811.63.8
Kotak Emerging Equity Scheme Growth ₹47.172
↑ 1.10
₹7,66813.948.118.35.312.38.9
TATA Mid Cap Growth Fund Growth ₹166.987
↑ 3.75
₹87512.743.619.15.110.26.5
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Small Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
Kotak Small Cap Fund Growth ₹92.369
↑ 2.40
₹1,85516.766.728.7511.65
SBI Small Cap Fund Growth ₹66.9168
↑ 1.53
₹5,42412.256.2254.815.56.1
Nippon India Small Cap Fund Growth ₹46.6905
↑ 1.16
₹9,3929.356.922.21.611.4-2.5
DSP BlackRock Small Cap Fund  Growth ₹67.262
↑ 1.23
₹5,32311.762300.69.50.7
ICICI Prudential Smallcap Fund Growth ₹29.47
↑ 0.57
₹1,44811.763.117.307.710
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Large & Mid Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
Mirae Asset Emerging Bluechip Fund Growth ₹66.46
↑ 0.53
₹11,92912.144.516.6916.214.7
Tata Large and Midcap Fund Growth ₹240.603
↑ 2.85
₹1,66610.938.910.66.79.913.9
Kotak Equity Opportunities Fund Growth ₹142.151
↑ 1.47
₹3,88512.137.1136.611.913.2
Canara Robeco Emerging Equities Growth ₹113.96
↑ 1.20
₹6,12611.942.119.36.612.88.7
Edelweiss Large and Mid Cap Fund  Growth ₹36.4
↑ 0.27
₹52810.837.111.46.610.611.1
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Equity Linked Savings Schemes (ELSS)

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
Canara Robeco Equity Tax Saver Growth ₹80.44
↑ 0.66
₹1,21611.937.718.811.312.110.7
Axis Long Term Equity Fund Growth ₹55.3316
↑ 0.40
₹22,632163913.711.112.914.8
Mirae Asset Tax Saver Fund Growth ₹21.737
↑ 0.09
₹4,463134714.99.4 14.1
BOI AXA Tax Advantage Fund Growth ₹68.34
↑ 0.91
₹31912.743.325.27.712.914.6
Invesco India Tax Plan Growth ₹59.33
↑ 0.37
₹1,15410.636.111.5711.19.4
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Diversified/Multi Cap Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
Parag Parikh Long Term Equity Fund Growth ₹33.8345
↑ 0.18
₹5,0086.636.727.513.914.214.4
UTI Equity Fund Growth ₹183.738
↑ 1.68
₹11,91716.948.622.713.112.911.7
Canara Robeco Equity Diversified Growth ₹162.88
↑ 0.70
₹2,46110.935.516.110.111.812.3
DSP BlackRock Equity Fund Growth ₹47.59
↑ 0.34
₹3,81912.538.212.47.711.817
Mirae Asset India Equity Fund  Growth ₹57.669
↓ -0.04
₹18,9999.438.86.86.712.412.7
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Sector Equity Mutual Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
UTI Healthcare Fund Growth ₹133.512
↑ 1.62
₹5866.432.65715.57.61.2
Nippon India Pharma Fund Growth ₹237.658
↑ 2.41
₹3,900731.15620.210.31.7
ICICI Prudential Technology Fund Growth ₹87.82
↑ 0.68
₹83219.470.655.92516.42.3
SBI Healthcare Opportunities Fund Growth ₹184.98
↑ 1.56
₹1,4457.133.154.713.24.8-0.5
TATA India Pharma & Healthcare Fund Growth ₹14.1168
↑ 0.16
₹3547.530.15017.6 5.5
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Focused Equity Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
IIFL Focused Equity Fund Growth ₹21.1349
↑ 0.24
₹1,0141443.919.311.314.627.3
Axis Focused 25 Fund Growth ₹34.49
↑ 0.18
₹11,89514.941.912.810.714.814.7
SBI Focused Equity Fund Growth ₹166.59
↑ 0.73
₹10,6209.333.898.612.616.1
Motilal Oswal Focused 25 Fund  Growth ₹26.798
↓ 0.00
₹1,34013.835.812.98.411.317.1
Principal Focused Multicap Fund Growth ₹76.85
↑ 0.21
₹58611.634.112.57.81111.8
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Dividend Yield Equity Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
UTI Dividend Yield Fund Growth ₹72.2033
↑ 0.32
₹2,2345.930.710.65.29.13.3
Principal Dividend Yield Fund Growth ₹61.11
↑ 0.33
₹1669.333.112.5511.94.4
Templeton India Equity Income Fund Growth ₹51.937
↑ 0.22
₹8081140.213.33.395.3
Aditya Birla Sun Life Dividend Yield Fund Growth ₹177.19
↑ 2.02
₹6635.73411.6-0.35.53.5
ICICI Prudential Dividend Yield Equity Fund Growth ₹16.62
↑ 0.22
₹1536.935.25.6-2.76.2-2.9
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

5 Best Value Equity Funds

FundNAVNet Assets (Cr)3 MO (%)6 MO (%)1 YR (%)3 YR (%)5 YR (%)2019 (%)
UTI Value Opportunities Fund Growth ₹71.7599
↑ 0.32
₹4,42712.238.712.97.39.510.4
ICICI Prudential Value Discovery Fund Growth ₹162.08
↓ -0.09
₹15,4227.330.913.73.970.6
JM Value Fund Growth ₹35.7898
↑ 0.22
₹10813.8406.52.811.511.9
Nippon India Value Fund Growth ₹81.4297
↑ 0.54
₹2,86710.643.392.88.55.7
Tata Equity PE Fund Growth ₹146.963
↑ 1.00
₹4,42710.234.36.2211.25.3
Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 27 Nov 20

*Below is list of Equity Funds having AUM >= 50 Crore having best returns in last 1 Year.

1. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a CAGR/Annualized return of 14.3% since its launch.  Ranked 40 in Sectoral category.  Return for 2019 was 1.2% , 2018 was -7.5% and 2017 was 6.2% .

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund
Growth
Launch Date 28 Jun 99
NAV (27 Nov 20) ₹133.512 ↑ 1.62   (1.23 %)
Net Assets (Cr) ₹586 on 31 Oct 20
Category Equity - Sectoral
AMC UTI Asset Management Company Ltd
Rating
Risk High
Expense Ratio 2.59
Sharpe Ratio 1.49
Information Ratio 0.56
Alpha Ratio 8.16
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Oct 15₹10,000
31 Oct 16₹9,297
31 Oct 17₹8,425
31 Oct 18₹8,458
31 Oct 19₹8,101
31 Oct 20₹12,515

UTI Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹367,070.
Net Profit of ₹67,070
Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Nov 20

DurationReturns
1 Month 3.3%
3 Month 6.4%
6 Month 32.6%
1 Year 57%
3 Year 15.5%
5 Year 7.6%
10 Year
15 Year
Since launch 14.3%
Historical performance (Yearly) on absolute basis
YearReturns
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
2014 43.7%
2013 23.3%
2012 24.8%
2011 -9.6%
2010 37.4%
Fund Manager information for UTI Healthcare Fund
NameSinceTenure
V Srivatsa3 Mar 173.67 Yr.

Data below for UTI Healthcare Fund as on 31 Oct 20

Equity Sector Allocation
SectorValue
Health Care93.17%
Basic Materials2.61%
Asset Allocation
Asset ClassValue
Cash4.22%
Equity95.78%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
10%₹61 Cr124,140
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
10%₹58 Cr1,239,120
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
8%₹47 Cr627,094
↑ 67,819
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
7%₹44 Cr139,142
↓ -9,278
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
7%₹39 Cr505,945
↑ 196,705
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321
6%₹37 Cr877,425
↑ 29,214
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Jan 14 | 524494
6%₹35 Cr150,995
↓ -13,432
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 540596
4%₹23 Cr456,812
↑ 10,000
Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 532523
4%₹22 Cr533,700
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Jan 20 | NH
4%₹21 Cr614,870

2. Nippon India Pharma Fund

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a CAGR/Annualized return of 21.2% since its launch.  Ranked 35 in Sectoral category.  Return for 2019 was 1.7% , 2018 was 3.6% and 2017 was 7.6% .

Below is the key information for Nippon India Pharma Fund

Nippon India Pharma Fund
Growth
Launch Date 5 Jun 04
NAV (27 Nov 20) ₹237.658 ↑ 2.41   (1.02 %)
Net Assets (Cr) ₹3,900 on 31 Oct 20
Category Equity - Sectoral
AMC Nippon Life Asset Management Ltd.
Rating
Risk High
Expense Ratio 2.33
Sharpe Ratio 1.39
Information Ratio 1.25
Alpha Ratio 5.26
Min Investment 5,000
Min SIP Investment 100
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Oct 15₹10,000
31 Oct 16₹9,393
31 Oct 17₹8,479
31 Oct 18₹9,907
31 Oct 19₹9,440
31 Oct 20₹14,106

Nippon India Pharma Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹395,578.
Net Profit of ₹95,578
Invest Now

Returns for Nippon India Pharma Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Nov 20

DurationReturns
1 Month 4.9%
3 Month 7%
6 Month 31.1%
1 Year 56%
3 Year 20.2%
5 Year 10.3%
10 Year
15 Year
Since launch 21.2%
Historical performance (Yearly) on absolute basis
YearReturns
2019 1.7%
2018 3.6%
2017 7.6%
2016 -10.6%
2015 19.4%
2014 49.5%
2013 20.9%
2012 34.8%
2011 -11%
2010 31.9%
Fund Manager information for Nippon India Pharma Fund
NameSinceTenure
Sailesh Raj Bhan1 Apr 0515.6 Yr.
Kinjal Desai25 May 182.44 Yr.

Data below for Nippon India Pharma Fund as on 31 Oct 20

Equity Sector Allocation
SectorValue
Health Care96.52%
Asset Allocation
Asset ClassValue
Cash3.48%
Equity96.52%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
10%₹377 Cr1,200,075
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA
10%₹373 Cr8,000,976
↑ 400,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Dec 15 | AUROPHARMA
9%₹364 Cr4,710,000
↓ -200,000
Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 500087
9%₹355 Cr4,700,000
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 500257
9%₹346 Cr3,800,025
↓ -200,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | 500124
8%₹293 Cr600,000
↓ -125,000
Thyrocare Technologies Ltd (Healthcare)
Equity, Since 31 May 16 | THYROCARE
7%₹267 Cr2,323,279
↓ -531,640
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 18 | 532321
5%₹198 Cr4,748,982
↑ 750,000
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Aug 18 | 532843
5%₹181 Cr14,403,541
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP
4%₹172 Cr811,506
↑ 519,003

3. ICICI Prudential Technology Fund

To generate long-term capital appreciation for you from a portfolio made up predominantly of equity and equity-related securities of technology intensive companies.

ICICI Prudential Technology Fund is a Equity - Sectoral fund was launched on 3 Mar 00. It is a fund with High risk and has given a CAGR/Annualized return of 11% since its launch.  Ranked 37 in Sectoral category.  Return for 2019 was 2.3% , 2018 was 19.1% and 2017 was 19.8% .

Below is the key information for ICICI Prudential Technology Fund

ICICI Prudential Technology Fund
Growth
Launch Date 3 Mar 00
NAV (27 Nov 20) ₹87.82 ↑ 0.68   (0.78 %)
Net Assets (Cr) ₹832 on 31 Oct 20
Category Equity - Sectoral
AMC ICICI Prudential Asset Management Company Limited
Rating
Risk High
Expense Ratio 2.6
Sharpe Ratio 1.11
Information Ratio -0.42
Alpha Ratio 3.49
Min Investment 5,000
Min SIP Investment 100
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Oct 15₹10,000
31 Oct 16₹8,986
31 Oct 17₹9,856
31 Oct 18₹13,875
31 Oct 19₹13,542
31 Oct 20₹19,575

ICICI Prudential Technology Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹458,689.
Net Profit of ₹158,689
Invest Now

Returns for ICICI Prudential Technology Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Nov 20

DurationReturns
1 Month 4.5%
3 Month 19.4%
6 Month 70.6%
1 Year 55.9%
3 Year 25%
5 Year 16.4%
10 Year
15 Year
Since launch 11%
Historical performance (Yearly) on absolute basis
YearReturns
2019 2.3%
2018 19.1%
2017 19.8%
2016 -4%
2015 3.9%
2014 26.3%
2013 62.6%
2012 17.1%
2011 -18.9%
2010 44.5%
Fund Manager information for ICICI Prudential Technology Fund
NameSinceTenure
Sankaran Naren14 Jul 173.3 Yr.
Priyanka Khandelwal8 Jul 200.32 Yr.
Vaibhav Dusad2 May 200.5 Yr.

Data below for ICICI Prudential Technology Fund as on 31 Oct 20

Equity Sector Allocation
SectorValue
Technology73.41%
Communication Services15.87%
Industrials5.29%
Consumer Defensive0.82%
Asset Allocation
Asset ClassValue
Cash4.61%
Equity95.39%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Infosys Ltd (Technology)
Equity, Since 30 Apr 08 | INFY
26%₹212 Cr2,001,286
↑ 275,000
Tech Mahindra Ltd (Technology)
Equity, Since 31 Oct 16 | 532755
7%₹58 Cr713,131
↑ 190,000
HCL Technologies Ltd (Technology)
Equity, Since 30 Sep 20 | HCLTECH
7%₹56 Cr668,118
↑ 478,118
Tata Consultancy Services Ltd (Technology)
Equity, Since 30 Sep 19 | TCS
6%₹47 Cr176,185
Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 20 | BHARTIARTL
5%₹43 Cr986,840
Coforge Ltd (Technology)
Equity, Since 31 Jul 20 | 532541
4%₹36 Cr161,520
↑ 111,335
IndiaMART InterMESH Ltd (Communication Services)
Equity, Since 30 Jun 20 | 542726
4%₹34 Cr70,356
↓ -6,000
Persistent Systems Ltd (Technology)
Equity, Since 31 May 20 | PERSISTENT
3%₹27 Cr230,157
↑ 111,169
Cyient Ltd (Industrials)
Equity, Since 30 Jun 18 | CYIENT
3%₹24 Cr602,383
↑ 200,000
Larsen & Toubro Infotech Ltd (Technology)
Equity, Since 31 Jul 16 | 540005
3%₹24 Cr80,750
↓ -8,038

4. SBI Healthcare Opportunities Fund

(Erstwhile SBI Pharma Fund)

To provide the investors maximum growth opportunity through equity investments in stocks of growth oriented sectors of the economy.

SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a CAGR/Annualized return of 14.3% since its launch.  Ranked 34 in Sectoral category.  Return for 2019 was -0.5% , 2018 was -9.9% and 2017 was 2.1% .

Below is the key information for SBI Healthcare Opportunities Fund

SBI Healthcare Opportunities Fund
Growth
Launch Date 31 Dec 04
NAV (27 Nov 20) ₹184.98 ↑ 1.56   (0.85 %)
Net Assets (Cr) ₹1,445 on 31 Oct 20
Category Equity - Sectoral
AMC SBI Funds Management Private Limited
Rating
Risk High
Expense Ratio 2.37
Sharpe Ratio 1.46
Information Ratio 0.03
Alpha Ratio 7.05
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-15 Days (0.5%),15 Days and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Oct 15₹10,000
31 Oct 16₹9,288
31 Oct 17₹8,195
31 Oct 18₹7,961
31 Oct 19₹7,542
31 Oct 20₹11,331

SBI Healthcare Opportunities Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹340,450.
Net Profit of ₹40,450
Invest Now

Returns for SBI Healthcare Opportunities Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Nov 20

DurationReturns
1 Month 3.8%
3 Month 7.1%
6 Month 33.1%
1 Year 54.7%
3 Year 13.2%
5 Year 4.8%
10 Year
15 Year
Since launch 14.3%
Historical performance (Yearly) on absolute basis
YearReturns
2019 -0.5%
2018 -9.9%
2017 2.1%
2016 -14%
2015 27.1%
2014 56.8%
2013 26%
2012 37.1%
2011 -5.5%
2010 29.1%
Fund Manager information for SBI Healthcare Opportunities Fund
NameSinceTenure
Tanmaya Desai1 Jun 119.43 Yr.

Data below for SBI Healthcare Opportunities Fund as on 31 Oct 20

Equity Sector Allocation
SectorValue
Health Care96.52%
Asset Allocation
Asset ClassValue
Cash3.12%
Equity96.88%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 20 | 500124
10%₹147 Cr300,000
Lupin Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500257
9%₹136 Cr1,500,000
↑ 100,000
Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 500087
9%₹136 Cr1,800,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA
9%₹130 Cr1,680,000
↑ 180,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
8%₹119 Cr380,000
↑ 20,000
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA
6%₹93 Cr2,000,000
Strides Pharma Science Ltd (Healthcare)
Equity, Since 31 Mar 14 | STAR
4%₹61 Cr889,892
↓ -10,108
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Dec 19 | NH
4%₹55 Cr1,600,000
Thyrocare Technologies Ltd (Healthcare)
Equity, Since 29 Feb 20 | THYROCARE
4%₹52 Cr448,749
↓ -101,251
Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Jul 20 | ALKEM
3%₹47 Cr180,000
↑ 60,000

5. TATA India Pharma & Healthcare Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a CAGR/Annualized return of 7.3% since its launch.  Return for 2019 was 5.5% , 2018 was -2.6% and 2017 was 4.7% .

Below is the key information for TATA India Pharma & Healthcare Fund

TATA India Pharma & Healthcare Fund
Growth
Launch Date 28 Dec 15
NAV (27 Nov 20) ₹14.1168 ↑ 0.16   (1.12 %)
Net Assets (Cr) ₹354 on 31 Oct 20
Category Equity - Sectoral
AMC Tata Asset Management Limited
Rating Not Rated
Risk High
Expense Ratio 2.61
Sharpe Ratio 1.46
Information Ratio 0.91
Alpha Ratio 11.22
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-3 Months (0.25%),3 Months and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Oct 16₹9,464
31 Oct 17₹8,622
31 Oct 18₹8,944
31 Oct 19₹9,081
31 Oct 20₹13,356

TATA India Pharma & Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹470,047.
Net Profit of ₹170,047
Invest Now

Returns for TATA India Pharma & Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Nov 20

DurationReturns
1 Month 3.5%
3 Month 7.5%
6 Month 30.1%
1 Year 50%
3 Year 17.6%
5 Year
10 Year
15 Year
Since launch 7.3%
Historical performance (Yearly) on absolute basis
YearReturns
2019 5.5%
2018 -2.6%
2017 4.7%
2016 -14.7%
2015
2014
2013
2012
2011
2010
Fund Manager information for TATA India Pharma & Healthcare Fund
NameSinceTenure
Rahul Singh20 Apr 200.53 Yr.
Meeta Shetty20 Apr 200.53 Yr.

Data below for TATA India Pharma & Healthcare Fund as on 31 Oct 20

Equity Sector Allocation
SectorValue
Health Care95.52%
Asset Allocation
Asset ClassValue
Cash4.48%
Equity95.52%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | 500124
14%₹49 Cr100,300
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA
9%₹32 Cr690,100
Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 500087
9%₹31 Cr410,000
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
8%₹29 Cr92,500
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 524494
8%₹29 Cr125,426
↑ 15,926
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 29 Feb 20 | NH
6%₹21 Cr626,720
Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 500257
5%₹18 Cr203,000
Laurus Labs Ltd (Healthcare)
Equity, Since 31 Jul 20 | 540222
5%₹18 Cr560,000
Syngene International Ltd (Healthcare)
Equity, Since 31 Jan 20 | 539268
4%₹14 Cr265,000
↑ 65,000
Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500126
4%₹13 Cr26,000

6. Franklin India Technology Fund

To provide long-term capital appreciation by predominantly investing in equity and equity related securities of technology and technology related companies.

Franklin India Technology Fund is a Equity - Sectoral fund was launched on 22 Aug 98. It is a fund with High risk and has given a CAGR/Annualized return of 18.9% since its launch.  Ranked 41 in Sectoral category.  Return for 2019 was 12.4% , 2018 was 11.9% and 2017 was 19.1% .

Below is the key information for Franklin India Technology Fund

Franklin India Technology Fund
Growth
Launch Date 22 Aug 98
NAV (26 Nov 20) ₹237.701 ↑ 0.64   (0.27 %)
Net Assets (Cr) ₹388 on 31 Oct 20
Category Equity - Sectoral
AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd
Rating
Risk High
Expense Ratio 2.46
Sharpe Ratio 1.22
Information Ratio 0.4
Alpha Ratio 7.37
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Oct 15₹10,000
31 Oct 16₹9,445
31 Oct 17₹10,610
31 Oct 18₹13,271
31 Oct 19₹13,436
31 Oct 20₹19,079

Franklin India Technology Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹458,689.
Net Profit of ₹158,689
Invest Now

Returns for Franklin India Technology Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Nov 20

DurationReturns
1 Month 3.8%
3 Month 15.3%
6 Month 50.7%
1 Year 48.2%
3 Year 22.6%
5 Year 16.3%
10 Year
15 Year
Since launch 18.9%
Historical performance (Yearly) on absolute basis
YearReturns
2019 12.4%
2018 11.9%
2017 19.1%
2016 -2.6%
2015 3.8%
2014 16.8%
2013 53.3%
2012 0.3%
2011 -15.5%
2010 32.6%
Fund Manager information for Franklin India Technology Fund
NameSinceTenure
Anand Radhakrishnan3 Mar 0713.68 Yr.
Varun Sharma30 Nov 154.93 Yr.
Pyari Menon26 Sep 191.1 Yr.

Data below for Franklin India Technology Fund as on 31 Oct 20

Equity Sector Allocation
SectorValue
Technology70.88%
Communication Services16.36%
Consumer Cyclical3.08%
Industrials2.2%
Financial Services0.7%
Real Estate0.32%
Health Care0.12%
Asset Allocation
Asset ClassValue
Cash6.09%
Equity93.75%
Other0.16%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Infosys Ltd (Technology)
Equity, Since 29 Feb 12 | INFY
26%₹100 Cr945,647
Tata Consultancy Services Ltd (Technology)
Equity, Since 31 Aug 04 | TCS
11%₹44 Cr164,086
↑ 34,086
Franklin Technology I Acc USD
Investment Fund | -
8%₹32 Cr91,868
HCL Technologies Ltd (Technology)
Equity, Since 30 Jun 14 | HCLTECH
8%₹32 Cr380,000
Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 18 | BHARTIARTL
7%₹26 Cr600,000
↑ 100,000
Info Edge (India) Ltd (Communication Services)
Equity, Since 31 Jan 17 | NAUKRI
4%₹16 Cr46,300
Tech Mahindra Ltd (Technology)
Equity, Since 28 Feb 14 | 532755
4%₹16 Cr200,000
Taiwan Semiconductor Manufacturing Co Ltd (Technology)
Equity, Since 30 Nov 18 | 2330
3%₹10 Cr88,000
Larsen & Toubro Infotech Ltd (Technology)
Equity, Since 30 Apr 19 | 540005
2%₹9 Cr31,000
Cognizant Technology Solutions Corp A (Technology)
Equity, Since 30 Apr 16 | CTSH
2%₹8 Cr15,960

Smart Tips to Choose Best Equity Funds for 2020

A perfect way to invest in the best equity mutual funds is by looking at its both qualitative and quantitative measures.

1. Qualitative Measures

a. Know Your Fund Manager

The credit of performance of a Mutual Fund scheme lies with the fund manager. A fund manager is responsible for making investment decisions for the fund’s portfolio. So, investors should go through the performance of the funds managed by the particular fund manager, especially during the tough market phases. Also, investors should give more priority to a fund manager who has an experience of managing a similar kind of funds, for example- small and mid caps. Going for a fund manager who has been consistent over his career is a preferred choice.

b. Fund House Reputation

While choosing the best equity mutual funds to invest, always look at the quality & reputation of the fund house. A fund house with a long-standing record, large assets under management, star funds or good performing fund etc., is the one to invest in. Hence a fund house having a strong presence in the financial industry with a consistent track record should be ideally preferred.

2. Quantitative Measures

a. Fund Performance

An investor should do a fair assessment of the funds’ performances for over a period of time. Also, it is suggested to go for a fund that consistently beats its benchmark over 4-5 years, additionally, one should see each period and see if the fund is able to beat the benchmark or not.

b. Size of the Fund

Investors should always go for a fund that is neither too big nor too small in size. While there is no perfect definition and relation between the size of the fund, it is said that both too small and too large, can hinder a fund’s performance. Thus, while choosing a fund, it is advisable to go for the one whose AUM (Asset Under Management) is approximately same as the category.

3. Additional Quantitative Measures

a. Expense Ratio

Investors who have Mutual Fund Investments have to bear certain charges like operation costs, management fees, etc., charged by the Asset Management Company (AMC). Generally, the expense ratio is higher for schemes that are actively managed than it is for passively managed schemes (such as Index Funds or ETFs). As per the SEBI rules, an expense ratio for equity funds are a minimum of 2.5%.However, the expense ratio is something which should not supersede other important factors such as fund performance etc. It is better to pay a higher expense ratio in a fund knowing that it will beat it competitors by a good margin.

b. Ratio Analysis

Some of the important ratios to measure fund performance are:

c. Alpha

Alpha is a measure of the success of your investment or rather outperformance against the benchmark. It measures on how much the fund or stock has performed in the general market. A positive alpha of 1 means that the fund has outperformed its benchmark index by 1%, while a negative alpha of -1 would indicate that the fund has produced 1% lower returns than its market benchmark. So, basically, an investor’s strategy should be to buy securities with positive alpha.

d. Beta

It measures volatility in a stock’s price or fund relative to a benchmark and is denoted in positive or negative figures. A Beta of 1 signifies that the stock’s price moves in line with the market, beta of a greater than 1 designates that the stock is riskier than the market, and a beta of less than 1 means that the stock is less risky than the market. So, lower beta is better in a falling market. In a rising market, high-beta is better.

e. Standard Deviation (SD)

In simple terms, SD is a statistical measure representing the volatility or risk in an instrument. The higher the SD, higher will be the fluctuations in the returns.

f. Sharpe Ratio

Sharpe Ratio measures returns (both negative & positive) with respect to the risk taken. Here the risk is defined by the Standard Deviation. A higher Sharpe ratio means, a higher return without too much risk. Thus, while investing, investors should choose a fund that shows a higher Sharpe ratio.

g. Sortino Ratio

The Sortino Ratio is a variation of Sharpe Ratio. But, unlike Sharpe ratio, Sortino ratio considers only the downside or negative return. Such a ratio is helpful for investors to assess risk in a better manner than just looking at the returns to the total volatility.

Upside Capture Ratio & Downside Capture Ratio

Upside/downside capture ratio guide an investor- whether a fund is outperformed i.e. gained more or lost less than a broad market benchmark- during the phase of the market upside (strong) or downside (weak), and more importantly by how much. Well, an upside ratio of over 100 means that a given fund has beaten the benchmark during the period of positive returns. And a downside ratio of less than 100 shows that a given fund has lost less than its benchmark during the phase of dull returns. So, generally, investors should go for a fund that has a lower downside capture ratio and a higher upside capture ratio.

Equity Fund Taxation

As per the Budget 2018 speech, a new Long Term Capital Gains (LTCG) tax on equity oriented mutual funds & stocks will be applicable from 1st April. The Finance Bill 2018 was passed by voice vote in Lok Sabha on 14th March 2018. Here’s how new income tax changes will impact the equity investments from 1st April 2018.

1. Long Term Capital Gains

LTCGs exceeding INR 1 lakh arising from redemption of Mutual Fund units or equities on or after 1st April 2018, will be taxed at 10 percent (plus cess) or at 10.4 percent. Long-term capital gains till INR 1 lakh will be exempt. For example, if you earn INR 3 lakhs in combined long-term capital gains from stocks or Mutual Fund investments in a financial year. The taxable LTCGs will be INR 2 lakh (INR 3 lakh - 1 lakh) and tax liability will be INR 20,000 (10 per cent of INR 2 lakh).

Long-term capital gains are the profit arising from selling or redemption of equity funds held more than a year.

2. Short Term Capital Gains

If Mutual Fund units are sold before one year of holding, Short Term Capital Gains (STCGs) tax will apply. The STCGs tax has been kept unchanged at 15 percent.

Equity Schemes Holding Period Tax Rate
Long Term Capital Gains (LTCG) More than 1 Year 10% (with no indexation)*****
Short Term Capital Gains (STCG) Less than or equal to a year 15%
Tax on Distributed Dividend - 10%#

*Gains up to INR 1 lakh are free of tax. Tax at 10% applies to gains above INR 1 lakh. Earlier rate was 0% cost calculated as closing price on Jan 31, 2018. #Dividend tax of 10% + Surcharge 12% + Cess 4% =11.648% Health & Education Cess of 4% introduced. Earlier, education Cess was 3%.

How to Invest in Best Equity Mutual Funds Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.

  2. Complete your Registration and KYC Process

  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest!

    Get Started

Conclusion

While looking for best equity mutual funds, investors should choose equity funds which are doing well in the market. One should know how a fund behaves and performs when the market goes bad. A deep analysis of fund’s last three years’ performances is an ideal way to buy one of the best equity mutual funds.

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
How helpful was this page ?
Rated 4.5, based on 84 reviews.
POST A COMMENT